ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

133 hedge funds and large institutions have $268M invested in Esperion Therapeutics in 2021 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 45 increasing their positions, 26 reducing their positions, and 49 closing their positions.

Holders
133
Holders Change
-6
Holders Change %
-4.32%
% of All Funds
2.05%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
44
Increased
45
Reduced
26
Closed
49
Calls
$5.13M
Puts
$3.51M
Net Calls
+$1.62M
Net Calls Change
+$3.75M

Top Buyers

1
DM
1
Deerfield Management
New York
$25M
2
WA
2
Wasatch Advisors
Utah
$31.9M
3
ACM
3
Altium Capital Management
New York
$12.6M
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$18.8M
5
MG
5
Meditor Group
Bermuda
$22.3M

Top Sellers

1
Marshall Wace
1
Marshall Wace
United Kingdom
$0
2
GIM
2
Granahan Investment Management
Massachusetts
$0
3
LA
3
Linden Advisors
New York
$0
4
CCM
4
Cinctive Capital Management
New York
$0
5
BNP Paribas Financial Markets
5
BNP Paribas Financial Markets
France
$29K
Name Market Value Shares Shares
Change 		Shares
Change %
MAM
176
McCarthy Asset Management
California
– – -100 Closed
Fifth Third Bancorp
177
Fifth Third Bancorp
Ohio
– – -50 Closed
HT
178
HAP Trading
New York
– – – –
CFGS
179
Concourse Financial Group Securities
Alabama
– – – –
Belvedere Trading
180
Belvedere Trading
Illinois
– – – –
CM
181
Caption Management
Oklahoma
– – – –
Wolverine Trading
182
Wolverine Trading
Illinois
– – – –
PNC Financial Services Group
183
PNC Financial Services Group
Pennsylvania
$0 35 – –
EI
184
Ellevest Inc
New York
$0 87 +11 +14%
Carson Wealth (CWM LLC)
185
Carson Wealth (CWM LLC)
Nebraska
$0 50 +50 New
LWA
186
Lenox Wealth Advisors
New York
$0 68 +68 New
AF
187
Advisornet Financial
Minnesota
$0 95 +95 New
4 5 6 7
8